Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
2 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
3 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
4 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
5 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
6 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
7 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
8 Completed Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
Condition: HIV Infection
Interventions: Procedure: GI endoscopy and GALT biopsies;   Biological: A sample of venous blood will also be collected
9 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
10 Unknown  Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: First-line Antiretroviral Therapy
11 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
12 Completed Observational Study of Blood Treated With Cytolin
Condition: HIV Infections
Intervention:
13 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
14 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir
15 Completed Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Echinacea
16 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
17 Active, not recruiting Cohort of HIV Associated Lymphomas
Condition: HIV Infection
Intervention:
18 Completed High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
19 Completed
Has Results
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
20 Unknown  The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Conditions: High Triglyceride Level;   HIV Infection
Intervention: Drug: Lovaza

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.